A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

N-Boc-D-proline | CAS 37784-17-1 - Request Quote

Picture of N-Boc-D-proline

N-Boc-D-proline

SZ CAT No:SZ-D036047
CAS No
37784-17-1
Mol.F.
C10H17NO4
Mol.Wt.
215.2
Inv. Status
Synthesis on demand
Rel. CAS No2687256-12-6 (potassium salt)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

N-Boc-D-proline is chemically (Tert-butoxycarbonyl)-D-proline. N-Boc-D-proline is supplied with detailed characterization data compliant with regulatory guideline. N-Boc-D-proline can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daclatasvir.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 37784-17-1

Purchase 37784-17-1

Order 37784-17-1

Enquire 37784-17-1

price of 37784-17-1

37784-17-1 Supplier

37784-17-1 Manufacturer

37784-17-1 Exporter

buy high quality N-Boc-D-proline

Purchase N-Boc-D-proline

N-Boc-D-proline suppliers

N-Boc-D-proline manufacturers

N-Boc-D-proline price

Order N-Boc-D-proline

Enquire N-Boc-D-proline

N-Boc-D-proline cost

N-Boc-D-proline Supplier

N-Boc-D-proline Distributor

N-Boc-D-proline for Method Validation

Daclatasvir Reference Standard

N-Boc-D-proline for ANDA Filing

N-Boc-D-proline for Forced Degradation Studies

N-Boc-D-proline Identification Standards

N-Boc-D-proline for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,